Anandita Agarwala

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia

Salim S. Virani, Pamela B. Morris, Anandita Agarwala et al. · Journal of the American College of Cardiology · 2021 · 321 citations

Medicine, Cardiology, Clinical Decision Support +14

NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient

Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala et al. · Journal of clinical lipidology · 2022 · 173 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease

Anandita Agarwala, Amrith Rodrigues, Marjorie Risman et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 106 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study

Anum Saeed, Wensheng Sun, Anandita Agarwala et al. · Atherosclerosis · 2018 · 84 citations

Medicine, Cardiology, Diabetology +15

The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study

Anandita Agarwala, Yashashwi Pokharel, Anum Saeed et al. · Atherosclerosis · 2017 · 60 citations

Medicine, Cardiology, Preventive Medicine +15